BERLIN, CAIRO and DUBAI, UAE, Nov. 30, 2022 /PRNewswire/ — Bioventure, a Dubai-based pharmaceutical company, Minapharm Pharmaceuticals, a Cairo-based pharmaceutical company, and MiGenTra GmbH, a Berlin-based pharmaceutical company, announced today the signing of an exclusive license agreement for the commercialization of multiple biosimilar candidates developed and manufactured by Alvotech, in Egypt and eighteen additional countries in Africa and the Middle

The UAE has strongly condemned the terrorist attack that targeted a hotel in the Somali capital, Mogadishu, which resulted in a number of deaths and injuries.In a statement, the Ministry of Foreign Affairs and International Cooperation (MoFAIC) affirme…

President His Highness Sheikh Mohamed bin Zayed Al Nahyan has sent a congratulatory message to President Klaus Werner Iohannis of Romania, on the occasion of his country’s National Day.His Highness Sheikh Mohammed bin Rashid Al Maktoum, Vice President,…

The National Human Rights Committee (NHRC) organized a workshop on the Universal Periodic Review of Human Rights in cooperation with the Universal Periodic Review Branch of the Office of the United Nations High Commissioner for Human Rights. His Excell…

His Excellency Dr. Mohammed Saeed Al Ariqi, UAE Ambassador to Kazakhstan, attended the inauguration of His Excellency Kassym-Jomart Tokayev, President of the Republic of Kazakhstan, for a new presidential term. The ceremony was held in the capital, Ast…

H.H. Sheikh Abdullah bin Zayed Al Nahyan, Minister of Foreign Affairs and International Cooperation, said that on this day, the UAE pays tribute to its martyrs who sacrificed their lives to defend the country and raise its flag high as a nation of hope…